These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36676646)

  • 1. A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma.
    Luo X; Wang Q; Tang H; Chen Y; Li X; Chen J; Zhang X; Li Y; Sun J; Han S
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676646
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
    Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
    Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics.
    Lin WW; Ou GY; Zhao WJ
    J Cell Mol Med; 2021 Nov; 25(21):10111-10125. PubMed ID: 34597473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of immune-related hub genes and construction of an immune-related gene prognostic index for low-grade glioma.
    Zhou J; Guo H; Liu L; Jin Z; Zhang W; Tang T
    J Cell Mol Med; 2023 Dec; 27(23):3851-3863. PubMed ID: 37775993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients.
    Shen HY; Xu JL; Zhu Z; Xu HP; Liang MX; Xu D; Chen WQ; Tang JH; Fang Z; Zhang J
    Neoplasia; 2023 Nov; 45():100942. PubMed ID: 37839160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
    Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
    Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma.
    Li J; Guo Q; Xing R
    BMC Cancer; 2023 Aug; 23(1):727. PubMed ID: 37543576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Panel for Immunotherapy in Low-Grade Glioma.
    Lv Q; Zhang Z; Fu H; Li D; Liu Y; Sun Y; Wu M
    World Neurosurg; 2024 Mar; 183():e825-e837. PubMed ID: 38216032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.
    Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L
    Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma.
    Huang Q; Yan J; Jiang Q; Guo F; Mo L; Deng T
    Medicine (Baltimore); 2023 Feb; 102(6):e32793. PubMed ID: 36820554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments.
    Wang C; Lu T; Xu R; Chang X; Luo S; Peng B; Wang J; Yao L; Wang K; Shen Z; Zhao J; Zhang L
    J Thorac Dis; 2022 Jun; 14(6):2131-2146. PubMed ID: 35813746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
    Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
    Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma.
    Tang G; Peng J; Huo L; Yin W
    BMC Bioinformatics; 2023 Jun; 24(1):225. PubMed ID: 37264314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.
    Zheng K; Hai Y; Chen H; Zhang Y; Hu X; Ni K
    J Transl Med; 2024 Apr; 22(1):365. PubMed ID: 38632658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an immune-related gene prognostic index for lung adenocarcinoma.
    Liu Z; Lei Y; Shen J; Zhao G; Wang X; Wang Y; Kudo Y; Liao J; Huang Y; Yu T
    J Thorac Dis; 2023 Nov; 15(11):6205-6227. PubMed ID: 38090291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses.
    Li J; Qiao H; Wu F; Sun S; Feng C; Li C; Yan W; Lv W; Wu H; Liu M; Chen X; Liu X; Wang W; Cai Y; Zhang Y; Zhou Z; Zhang Y; Zhang S
    Front Immunol; 2022; 13():998140. PubMed ID: 36275774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
    Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.